TY - JOUR
T1 - Induction of an epithelial integrin αVβ6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-β1 and increased collagen production
AU - Tabata, Takako
AU - Kawakatsu, Hisaaki
AU - Maidji, Ekaterina
AU - Sakai, Takao
AU - Sakai, Keiko
AU - Fang-Hoover, June
AU - Aiba, Motohiko
AU - Sheppard, Dean
AU - Pereira, Lenore
N1 - Funding Information:
Supported by the National Institutes of Health (grants AI46657 and AI53782 to L.P., HL53949 to D.S., DK74538 to T.S. ), the Thrasher Research Fund ( no. 02821-7 to L.P. ), the University of California San Francisco Academic Senate (to T.T.), and the American Heart Association (to H.K.).
PY - 2008/4
Y1 - 2008/4
N2 - Human cytomegalovirus (CMV) infection is a major cause of morbidity in immunosuppressed individuals, and congenital CMV infection is a leading cause of birth defects in newborns. Infection with pathogenic viral strains alters cell-cell and cell-matrix interactions, affecting extracellular matrix remodeling and endothelial cell migration. The multifunctional cytokine transforming growth factor (TGF)-β1 regulates cell proliferation, differentiation, and extracellular matrix remodeling. Secreted as a latent protein complex, TGF-β1 requires activation before binding to receptors that phosphorylate intracellular effectors. TGF-β1 is activated by integrin αvβ6, which is strongly induced in the epithelium by injury and inflammation but has not previously been found in endothelial cells. Here, we report that CMV infection induces integrin αvβ6 expression in endothelial cells , leading to activation of TGF-β1, signaling through its receptor ALK5, and phosphorylation of its intracellular effector Smad3. Infection of endothelial cells was also found to stimulate collagen synthesis through a mechanism dependent on both TGF-β1 and integrin αvβ6. Immunohistochemical analysis showed integrin αvβ6 up-regulation in capillaries proximal to foci of CMV infection in lungs, salivary glands, uterine decidua, and injured chorionic villi of the placenta, demonstrating both its induction in endothelium and upregulation in epithelium in vivo. Our results suggest that activation of TGF-β1 by integrin αvβ6 contributes to pathological changes and may impair endothelial cell functions in tissues that are chronically infected with CMV.
AB - Human cytomegalovirus (CMV) infection is a major cause of morbidity in immunosuppressed individuals, and congenital CMV infection is a leading cause of birth defects in newborns. Infection with pathogenic viral strains alters cell-cell and cell-matrix interactions, affecting extracellular matrix remodeling and endothelial cell migration. The multifunctional cytokine transforming growth factor (TGF)-β1 regulates cell proliferation, differentiation, and extracellular matrix remodeling. Secreted as a latent protein complex, TGF-β1 requires activation before binding to receptors that phosphorylate intracellular effectors. TGF-β1 is activated by integrin αvβ6, which is strongly induced in the epithelium by injury and inflammation but has not previously been found in endothelial cells. Here, we report that CMV infection induces integrin αvβ6 expression in endothelial cells , leading to activation of TGF-β1, signaling through its receptor ALK5, and phosphorylation of its intracellular effector Smad3. Infection of endothelial cells was also found to stimulate collagen synthesis through a mechanism dependent on both TGF-β1 and integrin αvβ6. Immunohistochemical analysis showed integrin αvβ6 up-regulation in capillaries proximal to foci of CMV infection in lungs, salivary glands, uterine decidua, and injured chorionic villi of the placenta, demonstrating both its induction in endothelium and upregulation in epithelium in vivo. Our results suggest that activation of TGF-β1 by integrin αvβ6 contributes to pathological changes and may impair endothelial cell functions in tissues that are chronically infected with CMV.
UR - http://www.scopus.com/inward/record.url?scp=42049097655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42049097655&partnerID=8YFLogxK
U2 - 10.2353/ajpath.2008.070448
DO - 10.2353/ajpath.2008.070448
M3 - Article
C2 - 18349127
AN - SCOPUS:42049097655
SN - 0002-9440
VL - 172
SP - 1127
EP - 1140
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 4
ER -